VANCOUVER, BC / ACCESSWIRE / February 26, 2021 / Core One Labs Inc.(CSE:COOL), (OTC PINK:CLABF), (Frankfurt:LD62, WKN:…
Category: Core One Labs
Core One Labs Finalizes Deal to Acquire Ketamine Infusions Centers of Texas, Entering the US Market for Psychedelic Treatments
VANCOUVER, BC / ACCESSWIRE / February 24, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62)(WKN:A2P8K3) (the “Company”…
Core One Labs Highlights Key Points from International Investor Call
VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / Core One Labs Inc.(CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3)…
Core One Labs Prepares First in Series of Patent Applications
VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / Core One Labs Inc.(CSE:COOL)(OTC Pink:CLABF)(Frankfurt:LD62, WKN:A2P8K3) (the “Company”…
Core One Labs Announces Its Entrance into the Ketamine Space with Proposed Acquisition of Ketamine Infusion Centers of Texas
VANCOUVER, BC / ACCESSWIRE / February 4, 2021 / Core One Labs Inc.(CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the…
Core One Labs Announces Vocan Assembles Equipment to Produce Biosynthesized Psilocybin
VANCOUVER, BC / ACCESSWIRE / January 23, 2021 / Core One Labs Inc.(CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62)(WKN:A2P8K3) (the “Company“) is…
Core One Labs Completes Sale of Non-Core Assets
VANCOUVER, BC / ACCESSWIRE / January 15, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the…
Core One Labs Announces Breakthrough in Solving Psilocybin Dosing Problems by Introducing Biosynthetic Psilocybin to its Patented Thinstrip Delivery Method
VANCOUVER, BC / ACCESSWIRE / January 12, 2021 / Core One Labs Inc.(CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the…
Leading Microbiologist, Dr. Robert E.W. Hancock Appointed as Executive Chairman of Core One Labs
VANCOUVER, BC / ACCESSWIRE / January 7, 2021 / Core One Labs Inc.(CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3)…